通过诱导本地菌体尾酒成功治疗患有慢性支气管切除症的患者:一个案例报告
David A Jernigan1, Roman D Hentish2
1Bioregulatory Medicine, Biologix Center for Optimum Health, Franklin, USA.
Cureus
|January 21, 2025
概括
诱导本地菌体尾酒为慢性支气管炎提供了一种新的治疗方法,有效向对多药耐药性感染. 这种方法在管理常规抗生素失败的复杂呼吸道疾病方面表现有前途.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 支气管病是一种慢性呼吸道疾病,支气管的扩张是永久的,导致持续的感染和抗生素耐药性.
- 传统的治疗方法与多微生物激活综合征 (MMAS) 斗争,并识别了诸如阿斯伯菌, Pseudomonas aeruginosa 和 Mycoplasma 等潜在的病原体.
- 尽管做了诊断工作,但大量的支气管切除病例仍然是异常病.
研究的目的:
- 介绍诱导本地菌体尾酒在治疗多微生物激活综合征的严重非囊性纤维化支气管切除症的长期结果.
- 在一个患有终身喘和慢性支气管病的患者的案例研究中证明菌体治疗的疗效.
主要方法:
- 利用诱导原生菌体疗法,特别是2024年引入的菌体尾酒.
- 采用一个案例研究方法,专注于一个45岁的男性,有20年的严重支气管切除和喘病史.
主要成果:
- 诱导的本地菌体尾酒在治疗患者的病情方面表现出速度,温和和有效性.
- 在治疗严重支气管炎症的多微生物激活综合征方面取得了成功的长期结果.
结论:
- 诱导本地菌体尾酒代表了急性和慢性混合感染的有前途的新疗法替代方案在支气管炎,包括多药耐药的病例.
- 菌体疗法提供了一种有针对性的方法,以消除支气管切除症患者具有挑战性的支气管环境中的特定病原体.
相关概念视频
01:30Lytic Cycle of Bacteriophages
70.2K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.2K
01:23Chronic Pharyngitis
1.1K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
1.1K
01:24Cystic Fibrosis: Management
139
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
139
01:28Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
01:26COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
01:28Pneumonia IV: Management
296
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296